massarray kit system (agena bioscience)

agena bioscience is a verified supplier

agena bioscience manufactures this product

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

agena bioscience massarray kit system
Massarray Kit System, supplied by agena bioscience, used in various techniques. Bioz Stars score: 97/100, based on 19529 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarray+analyzer+four+system/MassARRAY+Analyzer+Four+System%2C+384+Genotyping/pmc11542149-168-22-29
Average 97 stars, based on 19529 article reviews

massarray kit system - by Bioz Stars, 2026-10

97/100 stars

Images

other:

Article Title: The Clinical Outcomes of Different First-Line EGFR - TKIs Plus Bevacizumab in Advanced EGFR -Mutant Lung Adenocarcinoma
Article Snippet: The detection procedure was according to the user’s manual of the MassARRAY System (Cat. No.10411, SEQUENIM, San Diego, CA acquired by Agena Bioscience, http://agenabio.com/ , San Diego, CA in 2014).

Article Title: Importance of driver gene mutation assessment and targeted therapy for patients with early‑stage non‑small cell lung cancer and non‑R0 resection
Article Snippet: The Typlex/iPlex PRO kit (cat. no. 10217; Agena Bioscience, Inc.) was utilized for biochemical reactions according to the manufacturer's instructions for the MassARRAY kit system (cat. no. 10411; Agena Bioscience, Inc.).

Article Title: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M
Article Snippet: For tumor tissue detection, the detection procedure was according to the user’s manual of the MassARRAY ® System (Cat. No.10411, SEQUENIM, San Diego, CA acquired by Agena Bioscience, http://agenabio.com/ , San Diego, CA at 2014).

Article Title: The Difference in Clinical Outcomes Between Osimertinib and Afatinib for First-Line Treatment in Patients with Advanced and Recurrent EGFR-Mutant Non-Small Cell Lung Cancer in Taiwan.
Article Snippet: The detection procedure was performed according to the user’s manual of the MassARRAY ® System (Cat. No. 10411, SEQUENIM, San Diego, CA, USA acquired by Agena Bioscience, http:// agena bio. com/, San Diego, CA, USA in 2014).

Article Title: The Difference in Clinical Outcomes Between Osimertinib and Afatinib for First-Line Treatment in Patients with Advanced and Recurrent EGFR- Mutant Non-Small Cell Lung Cancer in Taiwan
Article Snippet: The detection procedure was performed according to the user’s manual of the MassARRAY ® System (Cat. No. 10411, SEQUENIM, San Diego, CA, USA acquired by Agena Bioscience, http://agenabio.com/ , San Diego, CA, USA in 2014).

Article Title: PD-L1 strong expressions affect the clinical outcomes of osimertinib in treatment naïve advanced EGFR -mutant non-small cell lung cancer patients
Article Snippet: The detection procedure was in accordance with the user’s manual provided in the MassARRAY® System (Cat. No.10411, SEQUENIM, San Diego, CA acquired by Agena Bioscience, http://agenabio.com/ , San Diego, CA in 2014).

Mass Spectrometry:

Article Title: Mutational monitoring of EGFR T790M in cfDNA for clinical outcome prediction in EGFR -mutant lung adenocarcinoma
Article Snippet: .. All nucleotide mass spectrometry assays were utilized MassARRAY System (Cat. No.10411, SEQUENIM, San Diego, CA acquired by Agena Bioscience, http://agenabio.com/ , San Diego, CA at 2014) according to users’ manual. ..

Review

massarray kit system (agena bioscience)

Structured Review

Images

Related Articles

other:

Mass Spectrometry:

Similar Products

Image Search Results